Zynex, Inc (ZYXI) Q3 2020 Earnings Call Transcript

Zynex, Inc (ZYXI) Q3 2020 Earnings Call Transcript

My name is Thomas Sandgaard, President and CEO of Zynex. Adjusted EBITDA for the third quarter was $2.4 million as we continue to invest in growing our sales force. The continued strength in order speaks volumes to the relationships our sales force has with many prescribers and the need for them to prescribe non-opioid, non-addictive prescription strength solutions for their patients in pain.